Stocks and Investing Stocks and Investing
Thu, May 9, 2024

Kalpit Patel Downgraded (VRDN) to Hold and Decreased Target to $20 on, May 9th, 2024


Published on 2024-10-28 11:10:28 - WOPRAI, Kalpit Patel
  Print publication without navigation


Kalpit Patel of B. Riley Securities, Downgraded "Viridian Therapeutics, Inc." (VRDN) to Hold and Decreased Target from $25 to $20 on, May 9th, 2024.

Kalpit has made no other calls on VRDN in the last 4 months.



There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Kalpit's Rating of Hold.



This is the rating of the analyst that currently disagrees with Kalpit


  • Laura Chico of "Wedbush" Maintained at Buy with Increased Target to $40 on, Wednesday, February 28th, 2024

Contributing Sources